Detection method of gallbladder-benefiting and pain-relieving mixture
By combining Yinchen and other drugs, the preparation of gallbladder-relieving and pain-relieving agents was solved, and the problem of Sinisan's unsatisfactory effect in the treatment of cholecystitis was solved, especially in abdominal pain and damp heat syndrome. It showed better results through thin layer identification and liquid phase Chromatography detects the drug content, achieving more efficient effects of promoting qi and relieving pain, and relieving gallbladder and reducing yellowing.
Patent Information
- Application Number
- CN202411155356.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing traditional Chinese medicine prescriptions such as Sinisan are not effective in treating cholecystitis, especially in improving abdominal pain and damp heat syndrome, which is difficult to meet clinical needs.
Use Yinchen, white peony, white flower snake tongue, fried chrysanthemum, Chuanxiong, vinegar, bupleurum, vinegar, yam, bran fried citrus aurantium, poria cocos, licorice, wild yam, wild chrysanthemum, turbid, moth, and fried chicken The combination of drugs such as Neugi, etc., was used to detect the content of white peony, Chuanxiong, and bran fried Citrus aurantium through thin-layer identification and liquid chromatography, and prepared a mixture of gallbladder and pain relief to enhance the effect of promoting qi and relieving pain, and relieving gallbladder and relieving yellowing.
It improves the effects of promoting qi and relieving pain, promoting gallbladder and reducing yellowing, and provides a more ideal Chinese medicine prescription, suitable for the clinical treatment of cholecystitis, especially in improving abdominal pain and damp heat syndrome.
Smart Images

Figure CN118961937A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedicine, and in particular relates to a method for detecting a gallbladder-promoting and analgesic mixture. Background Art
[0002] The proportion of patients with chronic cholecystitis in the outpatient department of gastroenterology in primary hospitals is high. Western medicine treatment is not ideal, and the disease recurs repeatedly. The patient's mood is very painful due to long-term illness, and he often chooses surgical resection in the end. Traditional Chinese medicine believes that cholecystitis is closely related to the liver, spleen, and stomach organs. The liver, spleen, and stomach are connected to the meridians and are mutually exterior and interior. The disease is mostly caused by damp heat, qi stagnation, and gallstones, which lead to gallbladder dysfunction, liver dysfunction, gallbladder stagnation, and spleen and stomach disorders. Clinically, liver and gallbladder damp-heat syndrome is the most common. The treatment should focus on soothing the liver and gallbladder, clearing heat and dampness, and promoting qi and unblocking the bowels. The traditional classic prescription Sini San is the most commonly used basic prescription for the treatment of cholecystitis. In the prescription, Bupleurum is the main medicine, which can soothe liver qi and raise the spleen and stomach to clear yang qi; white peony is the minister medicine, which can benefit yin and blood, restrain liver yin, and relieve the stomach; Citrus aurantium can disperse qi and resolve knots, purge heat and reduce turbidity; and Zhigancao can relieve urgency and stop pain, benefit the spleen and harmonize the stomach. Bupleurum and Zhishi are both ascending and descending, raising the clear and descending the turbid, and dredging the Yang Qi; white peony root and Zhishi are both blood and Qi, and harmonize the blood and Qi; the four herbs work together to soothe the liver and spleen, and relieve depression and heat. However, Sinisan is not ideal as a reconciling agent in the clinical application of cholecystitis, especially for improving abdominal pain and damp-heat syndrome, and often needs to be modified to be effective.
[0003] White peony root is the dried root of Paeonia lactiflora Pall. of the Ranunculaceae family. Fried white peony root with bran is the processed product of white peony root. In the Chinese Pharmacopoeia, the thin layer chromatography identification and content determination of white peony root both use paeoniflorin as the reference substance.
[0004] The main components of white peony are monoterpenes (peonidin, oxidized paeonidin, hydroxypeonidin, benzoylpeonidin, paeonidin lactone, paeonidin sulfite, peony glycoside, peony glycoside, white paeony glycoside, white paeony glycoside, etc.), triterpenes (oleanolic acid, betulinic acid, ivy sapogenin, etc.), flavonoids (kaempferol-3-O-β-D-glucoside, kaempferol-3-7-di-β-D-glucoside, etc.), polysaccharides, tannins, volatile oils (butanol, benzaldehyde, phenylacetaldehyde, methyl salicylate, etc.) and other types (benzoic acid, vanillic acid, syringic acid, glucose, arabinose, etc.). White peony has multiple pharmacological activities such as anti-inflammatory and analgesic, improvement of myocardial hypertrophy, anti-thrombotic, laxative, improvement of strabismic amblyopia, hypoglycemic, improvement of osteoarthritis, anti-depression, liver protection, lipid-lowering, and improvement of ischemia-reperfusion.
[0005] Smilax glabra is the dried rhizome of Smilax glabra Roxb. in the Liliaceae family. Astilbin is used as a reference substance in thin layer identification and content determination in the Chinese Pharmacopoeia.
[0006] The main chemical components of Smilax glabra include flavonoids (astilbin, quercetin, naringenin, dihydrokaempferol, Smilax glabra, luteolin, etc.), phenylpropanoids (resveratrol), lignans, steroids (β-sitosterol, carotene, stigmasterol, sarsaponin, tigera saponin, diosgenin), organic acids (syringic acid, 5-O-caffeoylshikimic acid, etc.), volatile oils, etc. Smilax glabra has obvious pharmacological activities in anti-inflammatory, analgesic, cardiovascular system, immune system and tumor.
[0007] Citrus aurantium is the dried immature fruit of Citrus aurantium L. and its cultivars of the Rutaceae family. Stir-fried Citrus aurantium with bran is a medicinal material made by stir-frying Citrus aurantium. The identification and content determination of stir-fried Citrus aurantium with bran in the Chinese Pharmacopoeia are the same as those of Citrus aurantium, and both use naringin and neohesperidin as reference substances.
[0008] The chemical composition of Citrus aurantium is complex. It is generally believed that it contains volatile oils, alkaloids, flavonoids, triterpenoid lactones, coumarins, vitamins, pectin and other ingredients. Frying Citrus aurantium with wheat bran or honey bran can increase the content of flavonoid glycosides and reduce the content of fat-soluble components; after fermentation, the content of flavonoid glycosides decreases and the content of fat-soluble components increases. Compared with the raw product, 38 new compounds were produced in Citrus aurantium fried with bran, 48 new compounds were produced in Citrus aurantium fried with honey bran, and 77 new compounds were produced in Citrus aurantium fried with honey bran, among which limonene, γ-terpinene, β-myrcene, α-terpineol, 3,7-dimethyl-1,6-octadien-3-ol, (-)-spartol and other ingredients changed greatly. Fermentation of Citrus aurantium can produce three new components, namely, eriodictyol-7-O-glucoside, hesperidin-7-O-glucoside and 5-demethylnobiletin, and significantly increase the content of naringenin and hesperidin; stir-fried Citrus aurantium with bran and steamed Citrus aurantium without adding new components, but instead reduce the content of the original components, so it is speculated that the fermentation method can improve the biological activity and bioavailability of Citrus aurantium. The raw Citrus aurantium has a strong dryness, and after processing, it can alleviate the pungent and dryness and enhance the effect of regulating qi and strengthening the spleen. Stir-fried Citrus aurantium with bran can regulate qi, relieve fullness, and relieve stagnation and distension. It is used for chest and flank qi stagnation, distension and pain, indigestion, phlegm and fluid retention, and ptosis of organs. The characteristic spectrum of Fructus Aurantii Immaturus was established by high performance liquid chromatography, which can simultaneously determine the contents of six flavonoid glycosides, including neoerioglossin, naringin, naringin, hesperidin, neohesperidin and aurantium, providing a more comprehensive basis for the research on the quality standard of Fructus Aurantii Immaturus. Summary of the invention
[0009] In order to solve the above-mentioned technical problems, this application provides the following technical solutions:
[0010] The invention provides a detection method for a gallbladder-promoting and analgesic mixture, wherein the gallbladder-promoting and analgesic mixture comprises wormwood, white peony root, oldenlandia diffusa, stir-fried Chuanlianzi, chuanxiong, vinegar-cured northern bupleurum, vinegar-cured Corydalis, stir-fried fructus aurantii with bran, Poria, licorice, Smilax glabra, wild chrysanthemum, curcuma, Lysimachia chinensis, and stir-fried chicken gizzard lining; the detection method comprises thin layer identification of white peony root, chuanxiong, and stir-fried fructus aurantii with bran in the gallbladder-promoting and analgesic mixture, and determination of the contents of index components naringin and neohesperidin in stir-fried fructus aurantii with bran by liquid chromatography:
[0011] Wherein, the identification method of white peony root, chuanxiong and fried aurantium with bran comprises the following steps:
[0012] S11: Take an appropriate amount of Lidanxiaotong mixture, add ethyl acetate or methanol to extract, concentrate and redissolve to obtain the test solution A1;
[0013] S12: weighing a white peony root control sample, a chuanxiong root control sample or a stir-fried fructus aurantii with bran, and adding ethyl acetate to prepare a reference solution B1; the reference solution B1 is selected from a white peony root control solution, a chuanxiong root control solution or a stir-fried fructus aurantii with bran;
[0014] S13: Spot the test solution A1 and the reference solution B1 on the stationary phase respectively and place them in a developing agent for development, and observe the results after drying;
[0015] The content determination of naringin and neohesperidin comprises the following steps:
[0016] S21: Take an appropriate amount of Lidanxiaotong mixture, add methanol to dilute, filter, and obtain the test solution A2;
[0017] S22: weigh naringin reference substance and neohesperidin reference substance, and add methanol to prepare reference substance solution B2;
[0018] S23: respectively aspirating the test solution A2 and the reference solution B2 and injecting them into the liquid chromatograph for determination, and establishing the linear regression equations of naringin and neohesperidin according to the concentration and peak area of the determination result of the reference solution B2;
[0019] S24: Determine the contents of naringin and neohesperidin in the test solution A2 according to the linear regression equations of naringin and neohesperidin and the peak areas in the determination results of the test solution A2.
[0020] Preferably, the preparation method of the gallbladder-promoting and analgesic mixture comprises the following steps:
[0021] S31: By weight, 20 parts of Artemisia capillaris, 10 parts of vinegar Bupleurum, 20 parts of Curcuma, 15 parts of white peony root, 15 parts of Smilax glabra, 15 parts of Poria, 15 parts of Hedyotis diffusa, 20 parts of Lysimachia chinensis, 20 parts of Chrysanthemum indica, 15 parts of stir-fried Chicken's gizzard lining, 10 parts of vinegar Corydalis, 10 parts of stir-fried Toosendan fruit, 10 parts of stir-fried Fructus Aurantii Immaturus, 10 parts of Ligusticum chuanxiong and 6 parts of Licorice are respectively decocted twice with water, and filtered to obtain filtrates of various medicinal materials; wherein the first decoction method is: adding 6 times the total weight of solids in water, soaking for 0.5h, decocting for 0.5h, and filtering the remaining solids; the second decoction method is: adding 3 times the total weight of solids remaining after filtering in the first decoction, and decocting for 0.5h;
[0022] S32: Mix the filtrates of the medicinal material slices, concentrate under reduced pressure, add stevioside and water, and mix to obtain the choleretic and analgesic mixture.
[0023] Preferably, the method further comprises a characteristic spectrum analysis method of the drug, specifically: analyzing the liquid phase test sample of the gallbladder-relieving and analgesic mixture and the liquid phase test sample of a single medicinal material by liquid chromatography, and using the medicinal material having a characteristic index component and not interfering with other components as the index drug in the gallbladder-relieving and analgesic mixture; the index drug is selected from bran-fried Citrus aurantium and white peony root;
[0024] The chromatographic conditions of the liquid chromatography method for determining the index drug are as follows:
[0025] The chromatographic column was a carbon 18-modified silica gel column, the flow rate was 1 mL / min, and the injection volume was 20 μL;
[0026] The detector is a DAD detector with a detection wavelength of 200-400nm;
[0027] Mobile phase A is acetonitrile, mobile phase B is 0.1 wt % phosphoric acid aqueous solution, and the total volume of mobile phase A and mobile phase B is 100%;
[0028] Gradient conditions: the volume of mobile phase A is 3% at 0-5min, 3%-14% at 5-10min, 14% at 10-15min, 14% at 15-20min, 14%-22% at 20-25min, 22% at 25-30min, 22%-40% at 30-35min, 40% at 35-40min, 40%-100% at 40-45min, and 100% at 40-45min; wherein, the detection wavelength of fried Citrus aurantium with bran is 283nm; the detection wavelength of white peony root is 230nm.
[0029] Preferably, in step S11, the test solution A1 is obtained by extracting the gallbladder and analgesic mixture twice with ethyl acetate by shaking, evaporating under reduced pressure, and then adding ethyl acetate to dissolve it; or by evaporating the gallbladder and analgesic mixture under reduced pressure, and then adding methanol to dissolve it.
[0030] Preferably, in step S13, when the reference solution B1 is a white peony root reference sample, the developing agent is selected from a mixed solution of chloroform, ethyl acetate, methanol and formic acid; wherein the mass ratio of chloroform, ethyl acetate, methanol and formic acid is 40:5:10:0.2;
[0031] Furthermore, after drying, spray with a color developer and heat at 105°C for color development; the color developer is selected from a 5 wt% vanillin sulfuric acid ethanol solution; the chromatograms of the test solution A1 and the reference solution B1 are compared, and if blue-purple spots appear at the same position, it means that the sample to be tested contains white peony root.
[0032] Preferably, in step S13, when the reference solution B1 is a Chuanxiong reference sample, the developing agent is selected from a mixed solution of n-hexane and ethyl acetate; wherein the mass ratio of n-hexane to ethyl acetate is 3:1;
[0033] Furthermore, after drying, the results were observed using a 365 nm ultraviolet lamp; the chromatograms of the test solution A1 and the reference solution B1 were compared. If fluorescent spots appeared at the same position between the test sample and the corresponding reference solution, it indicated that the test sample contained Chuanxiong.
[0034] Preferably, in step S13, when the reference solution B1 is a stir-fried Fructus Aurantii Immaturus reference sample, the developing agent is selected from a mixed solution of chloroform, methanol and water; wherein the mass ratio of chloroform, methanol and water is 13:6:2;
[0035] Furthermore, after drying, the results are observed using a 365nm ultraviolet lamp; the chromatograms of the test solution A1 and the reference solution B1 are compared. If fluorescent spots appear at the same position between the test sample and the corresponding reference solution, it indicates that the test sample contains stir-fried Citrus aurantium.
[0036] Preferably, in the steps S22 and S23, methanol is used to prepare a reference solution with a concentration of 20-1020 μg / mL, and the determination is performed under the following chromatographic conditions:
[0037] The chromatographic column was a carbon 18 modified silica gel column, the column temperature was 30°C, the injection volume was 20 μL, the flow rate was 1.0 mL / min, the detector was a DAD detector, and the detection wavelength for determining naringin and neohesperidin was 283 nm.
[0038] The mobile phase A is a 0.1wt% phosphoric acid aqueous solution, and the mobile phase B is acetonitrile; the total volume of the mobile phase A and the mobile phase B is 100%, and gradient elution is performed; the gradient elution conditions are: the volume of the mobile phase B is 3% during 0-5min, the volume of the mobile phase B is 3%-14% during 5-10min, the volume of the mobile phase B is 14% during 10-15min, the volume of the mobile phase B is 14% during 15-20min, the volume of the mobile phase B is 14-22% during 20-25min, the volume of the mobile phase B is 22% during 25-30min, the volume of the mobile phase B is 22-40% during 30-35min, the volume of the mobile phase B is 40% during 30-40min, the volume of the mobile phase B is 40-95% during 35-40min, the volume of the mobile phase B is 95% during 40-45min, the volume of the mobile phase B is 95% during 45-50min, the volume of the mobile phase B is 95% to 3% during 50-60min, and the volume of the mobile phase B is 3%.
[0039] Preferably, in step S23, the linear regression equation of naringin is y1=32.719x1-92.667, R 2 =0.9999; where y1 is the peak area, x1 is the concentration of naringin, x1 = 25.5-408 μg mL -1 .
[0040] Preferably, in step S23, the linear regression equation of neohesperidin is y2=34.299x2-115.94, R 2 =0.9998; where y2 is the peak area, x2 is the concentration of neohesperidin, x2 = 25.5-408 μg·mL -1 .
[0041] The technical solution of the present invention has the following advantages over the prior art:
[0042] Based on his clinical experience, the famous old Chinese medicine doctor modified and modified Sini San (Bupleurum, White Peony Root, Citrus aurantium, and Glycyrrhiza uralensis) to make a proven recipe for promoting gallbladder and relieving pain. This recipe replaces Citrus aurantium in Sini San with Citrus aurantium, which has a better effect of promoting qi and relieving pain. On this basis, Artemisia capillaris and Lysimachia chinensis are added to promote gallbladder and relieve jaundice, Hedyotis diffusa and Chrysanthemum indicum are added to clear heat and detoxify, Smilax glabra is added to clear heat and remove dampness, Poria and Chicken Gizzard invigorate the spleen and eliminate dampness, Curcuma cools blood and relieves pain, Corydalis yanhusuo and Chuanlianzi promote qi and relieve pain, and Chuanxiong promotes blood circulation and relieves pain. In order to promote the transformation of clinical research results of traditional Chinese medicine, this prescription is used as the basis for the preparation name: Lidanxiaotong Mixture.
[0043] According to the prescription of Lidanxiaotong mixture, the invention refers to the requirements of Chinese Pharmacopoeia and relevant guidelines, and carries out thin layer identification (15 herbs), inspection items such as relative density, pH value, solid content, microbial limit, as well as characteristic spectrum analysis and quantitative analysis of index components (naringin and neohesperidin) on the preparation. BRIEF DESCRIPTION OF THE DRAWINGS
[0044] Figure 1 It is a thin layer chromatogram of white peony root; 1 is the white peony root control medicinal material, 2 to 4 are the test samples 20230101, 20230102, 20230103;
[0045] Figure 2 The thin layer chromatogram of Chuanxiong; 1 is the control drug of Chuanxiong, 2 to 4 are the test products 20230101, 20230102, 20230103;
[0046] Figure 3 It is a thin layer chromatogram of fried Citrus aurantium with bran; 1 is the reference medicinal material of fried Citrus aurantium with bran, and 2 to 4 are test samples 20230101, 20230102, and 20230103;
[0047] Figure 4 It is the HPLC characteristic spectrum of the Lidanxiaotong mixture sample at 230nm and 283nm;
[0048] Figure 5 The liquid chromatogram of fried Citrus aurantium with bran at 283 nm;
[0049] Figure 6 is the liquid chromatogram of white peony root at 230 nm;
[0050] Figure 7 It is the liquid chromatogram of the mixed reference substance solution in the determination of naringin and neohesperidin in Lidanxiaotong mixture;
[0051] Figure 8 This is the liquid chromatogram of the test solution in the determination of naringin and neohesperidin in Lidanxiaotong mixture. DETAILED DESCRIPTION
[0052] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.
[0053] Example 1 Preparation of mixture
[0054] (1) Raw materials and reagents
[0055] Chinese herbal medicine slices: Artemisia capillaris (batch number: 306005), white peony root (batch number: 220525), oldenlandia diffusa (batch number: 220428), stir-fried Toosendan fruit (batch number: 220226), Ligusticum chuanxiong (batch number: 220302), vinegar-cooked Bupleurum chinense (batch number: 220409), vinegar-cooked Corydalis yanhusuo (batch number: 220519), stir-fried Citrus aurantium with bran (batch number: 220304), Poria cocos (batch number: 211231), liquorice slices (batch number: 220305), Smilax glabra (batch number: 220102), wild chrysanthemum (batch number: 220426), Curcuma aromatica (batch number: 211211), Lysimachia chinensis (batch number: 221008), stir-fried chicken gizzard lining (batch number: 220413), etc., all of which were purchased from Nantong Mitsukoshi Chinese Herbal Medicine Slices Co., Ltd. Three batches of Lidanxiaotong Mixture (batch number: 230101, 230102, 230103, two parallel samples each) and negative control samples lacking Fructus Aurantii Immaturus were prepared by the preparation room of Hai'an Traditional Chinese Medicine Hospital. White Peony Root control medicinal material, batch number 120905-202011; Chuanxiong Rhizoma control medicinal material, batch number 120918-201813. All the above control medicinal materials were purchased from China Food and Drug Inspection Institute.
[0056] The preparation method of the gallbladder-promoting and pain-relieving mixture consists of the following steps:
[0057] ①Prescription composition: 120g of Artemisia capillaris, 60g of Bupleurum chinense with vinegar, 120g of Curcuma aromatica, 90g of White Peony Root, 90g of Smilax glabra, 90g of Poria cocos, 90g of Hedyotis diffusa, 120g of Centella asiatica, 120g of Chrysanthemum indicum, 90g of stir-fried Chicken Gizzard Stone, 60g of Corydalis yanhusuo with vinegar, 60g of stir-fried Toosendan Fructus, 60g of stir-fried Citrus aurantium with bran, 60g of Ligusticum chuanxiong, 36g of Licorice tablets, a total of 15 herbs.
[0058] ② Preparation method: prepare the above 15 kinds of slices according to the amount of prescription ①, add water and boil twice, add 6 times the amount of water of the slices for the first time, soak for 0.5h, boil for 0.5h, and filter; add 3 times the amount of water of the slices for the second time, boil for 0.5h, filter, combine the two extracts, concentrate under reduced pressure to about 900mL, add 0.20g of stevioside, add water to adjust the total amount to 1000mL, stir well, fill and sterilize.
[0059] Reagents: Thin layer chromatography silica gel plate type G, purchased from Qingdao Ocean Chemical Co., Ltd., Sinopharm Chemical Reagent Co., Ltd., and Yantai Jiangyou Silica Gel Development Co., Ltd.; analytical grade petroleum ether, chloroform, ethyl acetate, methanol, ethanol, etc., purchased from Anhui Zesheng Technology Co., Ltd.; pyrophosphoric acid, vanillin, aluminum trichloride, concentrated sulfuric acid, purchased from Sinopharm Chemical Reagent Co., Ltd.; Wahaha purified water, purchased from Hangzhou Wahaha Group Co., Ltd.
[0060] (2) Preparation of test samples
[0061] Test sample treatment method: ① Ethyl acetate test sample solution: Take 3 batches of samples and shake them evenly, measure 20mL, shake and extract twice with ethyl acetate, 20mL each time, take the ethyl acetate layer and evaporate it under reduced pressure, add 2mL of ethyl acetate to dissolve the residue, and use it as the ethyl acetate test solution. ② Methanol test solution: Take a batch of samples and shake them evenly, measure 10mL, evaporate them under reduced pressure, and dissolve the residue with 2mL of methanol, and use it as the methanol test solution.
[0062] Negative sample treatment method: ① Ethyl acetate: Shake some of the negative samples of medicinal materials evenly, take 5 mL of each, shake and extract twice with ethyl acetate, 5 mL each time, take the ethyl acetate layer and evaporate it under reduced pressure, add 2 mL of ethyl acetate to dissolve the residue, and use it as the ethyl acetate negative control solution.
[0063] ②Methanol: Shake some of the negative samples of medicinal materials evenly, take 5 mL of each, evaporate under reduced pressure, and dissolve the residue in 2 mL of methanol as the methanol negative sample solution.
[0064] According to the prescription of Lidanxiaotong Mixture, the preparation was identified by thin layer chromatography (14 herbs except stir-fried chicken gizzard lining). After research, the thin layer chromatography identification method of three herbs in this product, namely white peony root, chuanxiong and stir-fried aurantium, was established.
[0065] Example 2 Thin layer identification
[0066] (1) White Peony Root
[0067] Take 20mL of this product (Lidanxiaotong Mixture), add 40mL of ethyl acetate and shake to extract, take the ethyl acetate layer solution and evaporate to dryness, add 1mL of ethyl acetate to the residue to dissolve it, and use it as the test solution. Take another 0.5g of white peony root control medicinal material, add 5mL of ethyl acetate and shake to extract for 5 minutes, filter, and use it as the control medicinal solution. According to the thin layer chromatography method (Chinese Pharmacopoeia 2020 Edition-General Rules 0502), take 5μL of each of the above solutions and spot them on the same silica gel G thin layer plate, use chloroform-ethyl acetate-methanol-formic acid (40:5:10:0.2) as the developing agent, develop, take out, dry, spray with 5wt% vanillin sulfuric acid solution, and heat until the spots are clearly colored. In the chromatogram of the test sample, the same blue-purple spots appear at the corresponding position of the chromatogram of the control medicinal material. See Figure 1 .
[0068] (2) Chuanxiong
[0069] Take 0.1g of Chuanxiong reference medicinal material, add 5mL of ethyl acetate, ultrasonically extract for 5 minutes, filter, and use it as the Chuanxiong reference medicinal material solution. According to the thin layer chromatography method (Chinese Pharmacopoeia 2020 Edition-General Chapter 0502), 5μL of the test sample solution under Identification 2.5.1 and 5μL of the Chuanxiong reference medicinal material solution were respectively aspirated and spotted on the same silica gel G thin layer plate, and n-hexane-ethyl acetate (3:1) was used as the developing agent. Develop, take out, dry, and inspect under ultraviolet light (365nm). In the chromatogram of the test sample, fluorescent spots of the same color appeared at the corresponding position of the chromatogram of the control medicinal material. Results At the corresponding positions of the chromatograms of the control medicinal material and the reference substance, the three batches of test sample samples showed fluorescent spots of the same color. The spots were clear, the separation effect was good, and there was no interference from the negative control solution. See Figure 2 .
[0070] (3) Stir-fried Citrus aurantium with bran
[0071] Take 0.5g of the powder of the reference medicinal material of Fructus Aurantii Immaturus stir-fried with bran, add 5mL of ethyl acetate, extract by oscillation, and take the subsequent filtrate as the reference medicinal material solution of Fructus Aurantii Immaturus. According to the thin layer chromatography experiment (General Rule 0502) in the 20th edition of the Pharmacopoeia, 5μL of each of the three sample solutions of the reference medicinal material, the test solution, and the negative reference substance of Fructus Aurantii Immaturus were taken and spotted on the same silica gel G thin layer plate, and the lower layer solution of chloroform-methanol-water (13:6:2) was used as the developing agent. The plate was developed, taken out, dried, sprayed with 3% aluminum chloride ethanol solution, heated for about 5 minutes, and inspected under ultraviolet light (365nm) to observe the color position of the fluorescent spots of the test sample and the medicinal material. In the chromatogram of the test sample, fluorescent spots of the same color appeared at the corresponding position of the chromatogram of the control medicinal material. Results At the corresponding positions of the chromatograms of the control medicinal material and the reference substance, the three batches of test sample samples showed fluorescent spots of the same color, the spots were clear, the separation effect was good, and there was no interference from the negative control substance solution. See Figure 3 .
[0072] Example 3 Sample Inspection
[0073] Three batches of pilot samples, LD20230101, LD20230102, and LD20230103, were used for inspection according to the relevant provisions of Part IV of the Chinese Pharmacopoeia (2020 edition).
[0074] (1) Relative density
[0075] According to the relative density determination method 0601 of Part IV of the 2020 edition of the Chinese Pharmacopoeia, the relative density of three batches of pilot samples was measured (at room temperature). The results are shown in Table 1.
[0076] (2) pH value
[0077] According to the pH determination method in Part IV of the 2020 edition of the Chinese Pharmacopoeia, pH test paper was used to determine the pH values of three parallel samples. The results are shown in Table 1.
[0078] (3) Others
[0079] This product is a multi-dose packaged preparation. It is inspected according to the "volume method" under the [minimum filling inspection method] (General Rules 0942 of Part IV of the 2020 edition of the Pharmacopoeia of the People's Republic of China). The filling volume should comply with the regulations. The results are shown in Table 1. Included in the quality standard.
[0080] (4) Total solids
[0081] Refer to the test of the total solid content determination method (General Rule 3101) in the 2020 edition of the "Chinese Pharmacopoeia". Shake the decoction of Lidan Xiaotong in advance, use a pipette to accurately measure 1mL of Lidan Xiaotong water decoction into a 50mL evaporating dish (pre-weighed), place it in an oven at 105℃ to dry to constant weight (the difference between two consecutive weighings does not exceed 5mg), and accurately weigh it. Calculate as follows:
[0082]
[0083] Where c x is the total solid amount of the test sample, g·mL -1 ; W is the weight of the test sample after constant weight, g; V is the volume of the test sample, mL.
[0084] Three doses of Lidanxiaotong Mixture were taken and tested according to the above method. The results are shown in Table 1.
[0085] The three samples used were observed to be slightly darker in color than the decoction, with a slight precipitate that was easily dispersed by shaking; the aroma was fragrant, and the taste was spicy, slightly sour, and bitter. The content of the concentrate fluctuated more than that of the decoction due to the influence of process parameters such as volume change during the preparation process, but it did not affect the stability of the content of the finished product. According to the general rules of the Chinese Pharmacopoeia, the average relative density of the concentrate for gallbladder and pain relief was 1.04 (room temperature), the pH value was 4.8, and the solid content was 9.01%.
[0086] Table 1 Test results of Lidanxiaotong Mixture Concentrate
[0087] Serial number Relative density pH Solid content (%) Loading 1 1.04 5.0 9.10 Not less than 500mL 2 1.03 4.8 8.76 Not less than 500mL 3 1.04 4.6 9.12 Not less than 500mL average value 1.04 4.8 9.01 Not less than 500mL
[0088] (5) Microbial limit test
[0089] According to 1105 and 1106 of Part IV of the 2020 edition of the "Chinese Pharmacopoeia", the applicability of the microbial limit test method is investigated and a suitable test method is established.
[0090] According to the results of the applicability investigation, the three batches of pilot samples were counted using the plate method for aerobic bacteria, molds and yeasts; the control bacteria Escherichia coli and Salmonella were detected using conventional methods. The results are shown in Table 2 below.
[0091] Table 2 Results of microbial limit test for three batches of samples
[0092]
[0093] According to the microbial limit test method of 1105 and 1106 in Part IV of the 2020 edition of the Chinese Pharmacopoeia, the total number of aerobic bacteria in each milliliter of Lidan Xiaotong Mixture should be less than 10 cfu / mL, the total number of molds and yeasts should be less than 10 cfu / mL, and Escherichia coli (1 mL) and Salmonella (10 mL) should not be detected. All three batches of pilot samples of Lidan Xiaotong Mixture met the standards.
[0094] Example 4 Characteristic Spectrum Qualitative Analysis
[0095] Using Lidanxiaotong mixture, related single medicinal materials, and negative control medicinal materials as samples, the relevant liquid chromatography conditions were established and the main chemical components and sources of single medicinal materials in the preparation were analyzed.
[0096] (1) Raw materials and reagents
[0097] Decoction pieces, reference medicinal materials and reference substances, choleretic and analgesic mixture, and negative control test substances: same as TLC identification items.
[0098] Reagents: acetonitrile and methanol for chromatography, Shanghai Aladdin Biochemical Technology Co., Ltd.; Wahaha purified water, Hangzhou Wahaha Group Co., Ltd.
[0099] (2) Preparation of test samples
[0100] Preparation of single medicinal material test solution: Prepare according to the method under the Thin Layer Identification item of each medicinal material in the Chinese Pharmacopoeia 2020 edition.
[0101] ① Stir-fried Citrus aurantium with bran: accurately weigh 1.035g of crude powder of this product, place it in a stoppered conical flask, accurately add 100mL of methanol, weigh it, ultrasonicate it for 45min, cool it to room temperature, weigh it again, make up the lost weight with methanol, shake it well, and let it stand. Take an appropriate amount of solution and filter it with a 0.22μm organic microporous filter membrane to obtain the test solution.
[0102] ② White Peony Root: Accurately weigh 1.019g of crude powder of this product, place it in a stoppered conical bottle, accurately add 100mL of 30% ethanol, weigh it, ultrasonicate it for 45 minutes, cool it to room temperature, weigh it again, make up the lost weight with 60% ethanol, shake it well, and let it stand. Take an appropriate amount of solution and filter it with a 0.22μm organic microporous filter membrane to obtain the test solution.
[0103] (3) Chromatographic conditions
[0104] Agilent 1260 InfinityⅡ (DAD detector) system, Agilent Technologies, USA. The chromatographic column was Cosmosil5C18-MS-Ⅱ (4.6 mm×250 mm, 5 μm); the mobile phase was acetonitrile (A)-0.1% phosphoric acid aqueous solution (B) as gradient elution (0-5 min, 3% A; 5-10 min, 3%-14% A; 10-15 min, 14% A; 15-20 min, 14%-22% A; 20-25 min, 22% A; 25-30 min, 22%-40% A; 30-35 min, 40% A; 35-40 min, 40%-100% A; 40-45 min, 100% A); the detection wavelength was 200-400 nm full wavelength; the flow rate was 1.0 mL·min-1; the injection volume was 20 μL.
[0105] (4) Experimental results
[0106] The characteristic spectrum test results of Lidanxiaotong Mixture Concentrate are as follows Figure 4 Under the above optimized chromatographic conditions, the mixture has two main characteristic peaks. Figure 5 and Figure 6 ) were compared with the Chinese Pharmacopoeia and related literature, and it was confirmed that the chromatographic peak 1 (230nm) came from white peony root, and peaks 2 and 3 (283nm) came from bran-fried Citrus aurantium. The chromatographic peak of Anemarrhena asphodeloides was small, and the corresponding content in the mixture was low, so it was not included in the quality standard for the time being.
[0107] In the gallbladder-relieving and analgesic mixture, the main components 2 and 3 that can be identified are derived from fried Citrus aurantium with bran, and these main components can be selected for subsequent content analysis.
[0108] Example 5 Content Determination
[0109] Based on the above-mentioned thin layer identification and characteristic spectrum analysis results, the contents of the main components naringin and neohesperidin in the preparation were simultaneously determined to provide a reference for related process research.
[0110] (1) Raw materials, reagents and methods
[0111] ① Raw materials and reagents
[0112] Naringin (batch number 110722-202116; content 93.5%): China Institute for the Authentication of Pharmaceutical and Biological Products; Neohesperidin (batch number 111857-201804; content 99.4%): China Food and Drug Inspection Institutes; Lidanxiaotong Mixture (batch number: 230101, 230102, 230103, two parallel samples each), Citrus aurantium lacking samples: Hai'an Traditional Chinese Medicine Hospital;
[0113] Reagents: HPLC grade methanol, acetonitrile (OCEANPAK, Sweden), chromatographic grade phosphoric acid (Shanghai Aladdin Biochemical Technology Co., Ltd.); Wahaha purified water (Hangzhou Wahaha Group Co., Ltd.).
[0114] ② Preparation of test samples
[0115] Preparation of the test solution of the mixture: accurately measure 2 mL of the Lidanxiaotong mixture solution, place it in a 25 mL volumetric flask, add methanol, shake well, dilute to the mark, let it stand, take an appropriate amount of the solution through a 0.22 μm organic microporous filter membrane, and take the filtrate. Prepare the negative sample lacking Citrus aurantium in the same way.
[0116] Preparation of reference solution: Reference solution: Accurately weigh 10.20 mg of naringin reference substance and 10.20 mg of neohesperidin reference substance, place in a 10 mL volumetric flask, add appropriate amount of methanol and ultrasonically dissolve, cool to room temperature and then dilute to volume as the reference stock solution, in which the mass concentration of naringin is 1020 μg mL -1 , the mass concentration of neohesperidin is 1020 μg·mL -1 .
[0117] Control medicinal materials: Accurately weigh 1.035g of Citrus aurantium coarse powder, place in a stoppered conical flask, accurately add 100mL of methanol, weigh, ultrasonicate for 45min, cool to room temperature, weigh again, make up the lost weight with methanol, shake well, let stand. Take an appropriate amount of solution, filter with a 0.22μm organic microporous filter membrane to obtain the test solution.
[0118] ③Chromatographic conditions
[0119] The chromatographic column is Cosmosil 5C 18 -AR-Ⅱ (250mm×4.6mm, 5μm); acetonitrile (B)-0.1% phosphoric acid aqueous solution (A) as the mobile phase for gradient elution (0-5min, 3% B; 5-10min, 3%-14% B; 10-15min, 14% B; 15-20min, 14%-22% B; 20-25min, 22% B; 25-30min, 22%-40% B; 30-35min, 40% B; 35-40min, 40%-95% B; 40-45min, 95% B; 45-50min, 95%-3% B; 50-60min, 3% B); the detection wavelength of naringin and neohesperidin was 283nm; the flow rate was 1.0mL·min -1 ; Column temperature 30℃; Injection volume 20μL.
[0120] (2) Methodological investigation
[0121] ① Investigation of specific results
[0122] Accurately pipette 20 μL of the reference solution and the test solution, and inject according to the above chromatographic conditions to examine the specificity of the method. The specificity examination results are shown in Figure 7 and Figure 8 ,Compared with the reference solution and the reference medicinal material, the chromatogram of the test solution showed chromatographic peaks with consistent retention times at the same detection wavelength, indicating that the method has good specificity.
[0123] ②Linear relationship investigation
[0124] The regression equation of naringin is y=32.719x-92.667, R 2 =0.9999, naringin concentration is 25.50~408.0μg·mL -1 The linear relationship was good within the range; the regression equation of the neohesperidin reference substance was y=34.299x-115.94, R 2 =0.9998, hesperidin concentration is 25.50~408.0μg·mL -1 The linear relationship is good within the range.
[0125] ③Precision inspection
[0126] The results of precision investigation are shown in Table 3. The results of precision investigation show that the RSD of the peak area of naringin is 0.13%, and the RSD of the peak area of neohesperidin is 0.11%, and the instrument precision is good.
[0127] Table 3 Results of precision study on the determination of naringin and neohesperidin in Lidanxiaotong mixture
[0128]
[0129] ④ Repeatability study
[0130] The results of the repeatability test are shown in Table 4. The results of the repeatability test showed that the peak area RSD of naringin was 0.27%, and the peak area RSD of neohesperidin was 0.13%, with good reproducibility, which was suitable for this test sample preparation method.
[0131] Table 4 Repeatability test results of the determination of naringin and neohesperidin in Lidanxiaotong mixture
[0132]
[0133] ⑤Study on the stability of the test solution
[0134] The results of the stability investigation are shown in Table 5. The results show that the RSD of the peak area of naringin is 0.30%, and the RSD of the peak area of neohesperidin is 0.48%. The test solution has good stability within 24 hours.
[0135] Table 5 Stability test results of naringin and neohesperidin content determination in Lidanxiaotong mixture
[0136]
[0137] ⑥ Sample recovery rate
[0138] The results of sample recovery are shown in Table 6. The average sample recovery rates of naringin and neohesperidin were 102.5% and 99.5%, respectively, both between 95.00% and 105.00%, and the RSD values were 0.87% and 1.11%, respectively, indicating that this method can be used for the determination of naringin and neohesperidin in Lidanxiaotong mixture.
[0139] Table 6 Results of sample recovery for determination of naringin and neohesperidin in Lidanxiaotong mixture
[0140]
[0141] (3) Contents of naringin and neohesperidin in choleretic mixture
[0142] The results of the content determination of Lidanxiaotong mixture are shown in Table 7. The content of naringin in the mixture is 1.096-1.170 mg·mL -1 The content of neohesperidin is within the range of 1.069-1.149 mg·mL -1 within the range.
[0143] Table 7 Results of determination of naringin and neohesperidin content in Lidanxiaotong mixture
[0144]
[0145] Effect evaluation 1
[0146] The present invention has established a method for simultaneously determining naringin and neohesperidin in a gallbladder-relieving and analgesic mixture. The determination results of three batches of test samples show that the contents of the two index components are stable, and the process is feasible.
[0147] During the pilot study, the contents of naringin and neohesperidin were stable and can be selected as indicator components for process investigation.
[0148] Obviously, the above embodiments are merely examples for clear explanation and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the protection scope of the invention.
Claims
1. A method for detecting a gallbladder-promoting and analgesic mixture, wherein the gallbladder-promoting and analgesic mixture comprises Artemisia capillaris, white peony root, oldenlandia diffusa, stir-fried Toosendan fruit, Ligusticum chuanxiong, vinegar-soaked Bupleurum root, vinegar-soaked Corydalis, stir-fried Fructus Aurantii Immaturus with bran, Poria, liquorice, Smilax glabra, wild chrysanthemum, Curcuma aromatica, Lysimachia chinensis, and stir-fried chicken gizzard lining, characterized in that: The detection method includes thin layer identification of white peony root, chuanxiong and bran-fried aurantium in Lidanxiaotong mixture, and determination of the contents of the index components naringin and neohesperidin in bran-fried aurantium by liquid chromatography: Wherein, the identification method of white peony root, chuanxiong and fried aurantium with bran comprises the following steps: S11: Take an appropriate amount of Lidanxiaotong mixture, add ethyl acetate to extract, concentrate and redissolve to obtain the test solution A1; S12: weighing a white peony root control sample, a chuanxiong root control sample or a stir-fried fructus aurantii with bran, and adding ethyl acetate to prepare a reference solution B1; the reference solution B1 is a white peony root control solution, a chuanxiong root control solution or a stir-fried fructus aurantii with bran; S13: Spot the test solution A1 and the reference solution B1 on the stationary phase respectively and place them in a developing agent for development, and observe the results after drying; The content determination of naringin and neohesperidin comprises the following steps: S21: Take an appropriate amount of Lidanxiaotong mixture, add methanol to dilute, filter, and obtain the test solution A2; S22: weigh naringin reference substance and neohesperidin reference substance, and add methanol to prepare reference substance solution B2; S23: respectively aspirating the test solution A2 and the reference solution B2 and injecting them into the liquid chromatograph for determination, and establishing the linear regression equations of naringin and neohesperidin according to the concentration and peak area of the determination result of the reference solution B2; S24: Determine the contents of naringin and neohesperidin in the test solution A2 according to the linear regression equations of naringin and neohesperidin and the peak areas in the determination results of the test solution A2.
2. The detection method of the gallbladder-relieving and analgesic mixture as claimed in claim 1, characterized in that: The preparation method of the gallbladder-promoting and analgesic mixture comprises the following steps: S31: By weight, 20 parts of Artemisia capillaris, 10 parts of vinegar Bupleurum, 20 parts of Curcuma, 15 parts of white peony root, 15 parts of Smilax glabra, 15 parts of Poria, 15 parts of Hedyotis diffusa, 20 parts of Lysimachia chinensis, 20 parts of Chrysanthemum indica, 15 parts of stir-fried Chicken's gizzard lining, 10 parts of vinegar Corydalis, 10 parts of stir-fried Toosendan fruit, 10 parts of stir-fried Fructus Aurantii Immaturus, 10 parts of Ligusticum chuanxiong and 6 parts of Licorice are respectively decocted twice with water, and filtered to obtain filtrates of various medicinal materials; wherein the first decoction method is: adding 6 times the total weight of solids in water, soaking for 0.5h, decocting for 0.5h, and filtering the remaining solids; the second decoction method is: adding 3 times the total weight of solids remaining after filtering in the first decoction, and decocting for 0.5h; S32: Mix the filtrates of the medicinal material slices, concentrate under reduced pressure, add stevioside and water, and mix to obtain the choleretic and analgesic mixture.
3. The detection method of the gallbladder-relieving and analgesic mixture as claimed in claim 1, characterized in that: The invention also includes a characteristic spectrum analysis method of the drug, which specifically comprises: analyzing the liquid phase test sample of the gallbladder-relieving and analgesic mixture and the liquid phase test sample of a single medicinal material by liquid chromatography, and using the medicinal material having a characteristic index component and not interfering with other components as the index drug in the gallbladder-relieving and analgesic mixture; the index drug is selected from bran-fried Citrus aurantium and white peony root; The chromatographic conditions of the liquid chromatography method for determining the index drug are as follows: The chromatographic column was a carbon 18-modified silica gel column, the flow rate was 1 mL / min, and the injection volume was 20 μL; The detector is a DAD detector with a detection wavelength of 200-400nm; Mobile phase A is acetonitrile, mobile phase B is 0.1 wt % phosphoric acid aqueous solution, and the total volume of mobile phase A and mobile phase B is 100%; Gradient conditions: the volume of mobile phase A is 3% at 0-5min, 3%-14% at 5-10min, 14% at 10-15min, 14% at 15-20min, 14%-22% at 20-25min, 22% at 25-30min, 22%-40% at 30-35min, 40% at 35-40min, 40%-100% at 40-45min, and 100% at 40-45min; wherein, the detection wavelength of fried Citrus aurantium with bran is 283nm; the detection wavelength of white peony root is 230nm.
4. The detection method of the gallbladder-relieving and analgesic mixture as claimed in claim 1, characterized in that: In the step S11, the test solution A1 is obtained by extracting the gallbladder and analgesic mixture twice by shaking with ethyl acetate, evaporating under reduced pressure, and then adding ethyl acetate to dissolve it; or by evaporating the gallbladder and analgesic mixture under reduced pressure, and then adding methanol to dissolve it.
5. The detection method of the gallbladder-relieving and analgesic mixture as claimed in claim 1, characterized in that: In step S13, when the reference solution B1 is a white peony root reference sample, the developing agent is selected from a mixed solution of chloroform, ethyl acetate, methanol and formic acid; wherein the mass ratio of chloroform, ethyl acetate, methanol and formic acid is 40:5:10:0.
2.
6. The detection method of the gallbladder-relieving and analgesic mixture as claimed in claim 1, characterized in that: When the reference solution B1 uses the white peony root reference sample, it is sprayed with a color developer after drying and heated at 105°C until color is developed; the color developer is selected from a 5wt% vanillin sulfuric acid ethanol solution; the chromatograms of the test solution A1 and the reference solution B1 are compared, and if blue-purple spots appear at the same position, it means that the sample to be tested contains white peony root.
7. The detection method of the gallbladder-relieving and analgesic mixture as claimed in claim 1, characterized in that: In step S13, when the reference solution B1 is a Chuanxiong reference sample, the developing agent is selected from a mixed solution of n-hexane and ethyl acetate; wherein the mass ratio of n-hexane to ethyl acetate is 3:
1.
8. The detection method of the gallbladder-relieving and analgesic mixture as claimed in claim 1, characterized in that: In the step S13, when the reference solution B1 uses the stir-fried Fructus Aurantii Immaturus reference sample, the developing agent is selected from a mixed solution of chloroform, methanol and water; wherein the mass ratio of chloroform, methanol and water is 13:6:
2.
9. The method for detecting the gallbladder-relieving and analgesic mixture according to claim 7 or 8, characterized in that: When the reference solution B1 uses Chuanxiong or fried Fructus Aurantii Immaturus as the reference sample, the results are observed with a 365nm ultraviolet lamp after drying; The chromatograms of the test solution A1 and the reference solution B1 are compared. If fluorescent spots appear at the same position between the test solution and the corresponding reference solution, it means that the test solution contains Chuanxiong or Fructus Aurantii Immaturus.
10. The detection method of the gallbladder-relieving and analgesic mixture as claimed in claim 1, characterized in that: In the steps S22 and S23, methanol is used to prepare a reference solution with a concentration of 20-1020 μg / mL, and the measurement is performed under the following chromatographic conditions: The chromatographic column was a carbon 18 modified silica gel column, the column temperature was 30°C, the injection volume was 20 μL, the flow rate was 1.0 mL / min, the detector was a DAD detector, and the detection wavelength for determining naringin and neohesperidin was 283 nm. The mobile phase A is a 0.1wt% phosphoric acid aqueous solution, and the mobile phase B is acetonitrile; the total volume of the mobile phase A and the mobile phase B is 100%, and gradient elution is performed; the gradient elution conditions are: the volume of the mobile phase B is 3% during 0-5min, the volume of the mobile phase B is 3%-14% during 5-10min, the volume of the mobile phase B is 14% during 10-15min, the volume of the mobile phase B is 14% during 15-20min, the volume of the mobile phase B is 14-22% during 20-25min, the volume of the mobile phase B is 22% during 25-30min, the volume of the mobile phase B is 22-40% during 30-35min, the volume of the mobile phase B is 40% during 30-40min, the volume of the mobile phase B is 40-95% during 35-40min, the volume of the mobile phase B is 95% during 40-45min, the volume of the mobile phase B is 95% during 45-50min, the volume of the mobile phase B is 95% to 3% during 50-60min, and the volume of the mobile phase B is 3%.
Citation Information
Patent Citations
Thin-layer chromatography identification method of Danwei Kang capsule
CN112903897A
Detection method of intestine-strengthening and diarrhea-stopping mixture
CN114354813A
Traditional Chinese medicine compound composition for treating chronic cholecystitis as well as preparation method and application thereof
CN117838816A
Cited By
Fingerprint spectrum determination method of endothelium corneum gigeriae galli and chrysanthemum mixed plant solid beverage
CN121476492A
A fingerprint spectral determination method for a chicken gizzard and chrysanthemum mixed plant solid beverage
CN121476492B
